Powder: -20°C for 3 years | In solvent: -80°C for 1 year
JNK3 Inhibitor-3 (compound 15g) is a selective, blood-brain barrier permeable, and orally active inhibitor of c-Jun N-terminal kinase 3 (JNK3) with IC50 values of 147.8 nM, 44.0 nM, and 4.1 nM against JNK1, JNK2, and JNK3, respectively. This compound has been shown to significantly enhance memory in mouse models of dementia and is utilized in Alzheimer’s disease research [1].
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約8-10 週間 | ¥ 349,000 |
50 mg | 約8-10 週間 | ¥ 454,500 |
100 mg | 約8-10 週間 | ¥ 574,000 |
説明 | JNK3 Inhibitor-3 (compound 15g) is a selective, blood-brain barrier permeable, and orally active inhibitor of c-Jun N-terminal kinase 3 (JNK3) with IC50 values of 147.8 nM, 44.0 nM, and 4.1 nM against JNK1, JNK2, and JNK3, respectively. This compound has been shown to significantly enhance memory in mouse models of dementia and is utilized in Alzheimer’s disease research [1]. |
ターゲット&IC50 | JNK3:4.1 nM, JNK2:44 nM, JNK1:147.8 nM |
In vitro | JNK3 inhibitor-3, at concentrations ranging from 0 to 10 μM, exhibits inhibitory effects on JNK1, JNK2, and JNK3, with respective IC50s of 147.8, 44.0, and 4.1 nM. Additionally, at a 20 μM concentration and exposure times of 24 and 48 hours, the compound displays neuroprotective properties in vitro [1]. |
In vivo | JNK3 inhibitor-3, administered orally at doses of 30 and 60 mg/kg daily for 2 to 2.2 months, enhances memory in the 3xTg mouse model of dementia [1]. Regarding its pharmacokinetic properties in rats, after intravenous (IV) administration of 1 mg/kg, the area under the curve (AUC) is 1085.24 hr•ng/mL, and after oral (PO) administration of 3 mg/kg, the AUC is 2806.77 hr•ng/mL. The maximum concentration (Cmax) following IV administration is 1238.85 ng/mL, occurring at a peak time (Tmax) of 0.67 hours. The half-life (T1/2) is 0.36 hours IV and 1.14 hours PO, with a bioavailability (BA) of 86.21% [1]. |
分子量 | 467.52 |
分子式 | C26H25N7O2 |
CAS No. | 2873465-25-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
JNK3 inhibitor-3 2873465-25-7 MAPK JNK Inhibitor inhibitor inhibit